Articles tagged "Kidney transplantation"

2015 American Transplant Congress
Associations Between Deceased-Donor Urine Biomarkers of Kidney Injury and 6-Month Kidney Transplant Function
C. Parikh, I. Hall, M. Doshi, B. Schroppel, F. Weng, R. Hasz, P. Murray, V. Rao, H. Thiessen-Philbrook, J. Ficek, P. Reese.
TRIBE-AKI Consortium, New Haven, CT.
Assessment of organ quality is integral to allocation, yet existing tools have a limited ability to predict important transplant outcomes. We evaluated whether injury biomarkers,…
2015 American Transplant Congress
Fracture Incidence in Adult Kidney Transplant Recipients
K. Naylor,^1,2 S. Jamal,³ G. Zou,¹ E. McArthur,⁴ N. Lam,^1,2 W. Leslie,⁵ A. Hodsman,² J. Kim,^4,6 G. Knoll,⁷ L.-A. Fraser,¹ J. Adachi,⁸ A. Garg.^1,2,4
¹Western University, London, ON, Canada; ²London Health Sciences Centre, London, ON, Canada; ³Women's College Research Institute, Toronto, Canada; ⁴Institute for Clinical Evaluative Sciences, Toronto, Canada; ⁵University of Manitoba, Winnipeg, Canada; ⁶University Health Network, Toronto, Canada; ⁷Ottawa Hospital Research Institute, Ottawa, Canada; ⁸McMaster University, Hamilton, Canada.
Background: It remains uncertain whether kidney transplant recipients are a high risk group for fracture. We conducted this study to provide a precise estimate of…
2015 American Transplant Congress
HLA-DR Matching Improves Immunologic Outcomes in Elderly Kidney Transplant Recipients
F. Halleck, D. Khadzhynov, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
BACKGROUND: The Eurotransplant senior program (ESP) neglects HLA matching for elderly (>65y) KTR. Only few data exist regarding the influence of HLA-DR-matching on immunologic outcomes.PATIENTS…
2015 American Transplant Congress
24 Month Post Transplantation Follow Up of the Certitem Trial
E. Rondeau,¹ E. Cassuto,² V. Vuiblet,³ C. Legendre,⁴ P. Merville,⁵ Y. Le Meur,⁶ B. Moulin,⁷ P. Westeel,⁸ B. Hurault De Ligny,⁹ A. Lécuyer,¹⁰ M. Tindel,¹¹ N. Kamar.¹²
¹Hôpital Tenon, Paris, France; ²Hôpital Pasteur, Nice, France; ³Hôpital Maison Blanche, Reims, France; ⁴Hôpital Necker, Paris, France; ⁵Hôpital Pellegrin, Bordeaux, France; ⁶Hôpital La Cavale Blanche, Brest, France; ⁷Nouvel Hôpital Civil, Strasbourg, France; ⁸Hôpital Sud, Amiens, France; ⁹CHU, Caen, France; ¹⁰Novartis Pharma S.A.S, Rueil-Malmaison, France; ¹¹Keyrus Biopharma, Levallois-Perret, France; ¹²Hôpital Rangueil, Toulouse, France.
Background: CERTITEM has evaluated the effect of everolimus/calcineurin inhibitors free (CNI free) on fibrosis progression and results have been reported at 12 months (M12). Data…
2015 American Transplant Congress
NFAT Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients
V. Tatapudi, A. Webber, C. Leung, F. Vincenti.
Div. of Nephrology, Dept. of Medicine, University of California, San Francisco Medical Center, San Francisco, CA.
Purpose of Study:To demonstrate that profiling kidney transplant recipients (KTR) on Tacrolimus (Tac) based immunosuppression based on quantitative analysis of NFAT (nuclear factor of activated…
2015 American Transplant Congress
Impact of Subclinical Rejection (SCR) and Acute Clinical (ACR) in Renal Transplant Recipients
R. Mehta, P. Sood, A. Cherukuri, S. Chen, G. Mour, C. Wu, N. Shah, C. Puttarajappa, P. Randhawa, A. Tevar, S. Hariharan.
University of Pittsburgh Medical Center, Pittsburgh, PA.
The importance of diagnosing subclinical rejection and its short and long term impact remains controversial.We prospectively evaluated 296 patients who had a kidney transplant at…
2015 American Transplant Congress
The Impact of Ureteral Complications After Pediatric Renal Transplantation
J. Finkelstein,¹ J. Pak,¹ N. Jain,¹ P. Sandoval,² S. Alam.¹
¹Pediatric Urology/Nephrology, Morgan Stanley Children's Hospital, New York, NY; ²Surgery, Columbia University College of Physicians & Surgeons, New York, NY.
Introduction: The incidence of acute renal allograft rejection has declined with advances in immunosuppression, making the evaluation of other risk factors for graft failure vital.…
2015 American Transplant Congress
Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration
K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
OBJECTIVE:The efficacy of antiviral prophylaxis for rituximab (RIT)-associated hepatitis B virus (HBV) reactivation in patients with lymphoma has been recently reported. However, the immunological effect…
2015 American Transplant Congress
Disparities in Death and Delisting on the Waitlist for Renal Transplant in the United States
D. Keith, A. Nishio Lucar, G. Vranic.
Medicine, University of Virginia, Charlottesville, VA.
Waiting time to kidney transplant varies dramatically among organ procurement organizations (OPOs) in the US. We sought to evaluate the association between death and delisting…
2015 American Transplant Congress
Initial Experience With a Tailor-Made Simulation and Navigation Program Using a 3D Printer Model of Kidney Transplantation Surgery
M. Kusaka,¹ M. Sugimoto,² N. Fukami,¹ H. Sasaki,¹ M. Takenaka,¹ T. Ito,³ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
¹Department of Urology, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan; ²Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan; ³Department of Organ Transplant Surgery, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan.
Introduction: Three-dimensional (3D) printing systems allow for the creation of surgical models mimicking real tissue. We developed a kidney graft and pelvic cavity replica as…